Chlorzoxazone 250 mg, Nimesulide 100 mg, Paracetamol 325 mg Tablets

Paracetamol has analgesic and antipyretic activity. The cited product information associates its action with selective inhibition of prostaglandin synthesis; the mechanism is described as probable rather than fully established.

In the cited oral-tablet reference, absorption is rapid, with peak plasma levels about 30–60 minutes after a dose. The reported plasma half-life at therapeutic doses is 1–4 hours. Most drug-related material is recovered in urine within the first day. These tablet findings do not establish absorption of this catalogue formulation or an intravenous presentation.

Nimesulide inhibits cyclo-oxygenase-dependent prostaglandin synthesis. This archived mechanism reference is not a current prescribing recommendation; hepatic safety restrictions and local authorization must be checked separately.

The archived oral 100 mg reference reports plasma peaks at 2–3 hours, protein binding up to 97.5% and a half-life of 3.2–6 hours. Hepatic pathways include CYP2C9 and formation of an active hydroxylated metabolite. About 50% is eliminated through urine and 29% through feces after metabolism; only 1–3% is unchanged urinary drug. These findings are not controlled-release or injection data.

Chlorzoxazone is a centrally-acting agent for painful musculoskeletal conditions. Data available from animal experiments as well as human study indicate that chlorzoxazone acts primarily at the level of the spinal cord and subcortical areas of the brain where it inhibits multisynaptic reflex arcs involved in producing and maintaining skeletal muscle spasm of varied etiology. The clinical result is a reduction of the skeletal muscle spasm with relief of pain and increased mobility of the involved muscles. Blood levels of chlorzoxazone can be detected in people during the first 30 minutes and peak levels may be reached, in the majority of the subjects, in about 1 to 2 hours after oral administration of chlorzoxazone. Chlorzoxazone is rapidly metabolized and is excreted in the urine, primarily in a conjugated form as the glucuronide. Less than one percent of a dose of chlorzoxazone is excreted unchanged in the urine in 24 hours.